Center for Scientific Review; Amended Notice of Meeting, 8726 [2014-03106]

Download as PDF 8726 Federal Register / Vol. 79, No. 30 / Thursday, February 13, 2014 / Notices Special Minority Initiatives, National Institutes of Health, HHS). Dated: February 7, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–03110 Filed 2–12–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Neural Oxidative Metabolism and Death Study Section, February 20, 2014, 08:00 a.m. to February 21, 2014, 12:00 p.m., Fairmont Hotel San Francisco, 950 Mason Street, San Francisco, CA, 94108 which was published in the Federal Register on January 23, 2014, 79 FR 3836–3838. The meeting will be held at The Argonaut Hotel, 495 Jefferson Street, San Francisco, CA 94109. The meeting date and time remain the same. The meeting is closed to the public. Time: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Nitsa Rosenzweig, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1102, MSC 7760, Bethesda, MD 20892, (301) 435– 1747, rosenzweign@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: February 7, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–03108 Filed 2–12–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: February 7, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2014–03106 Filed 2–12–14; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/ contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Cancer Institute; Notice of Closed Meetings BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health emcdonald on DSK67QTVN1PROD with NOTICES Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.),notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Member Conflict: Biological Chemistry and Macromolecular Biophysics. Date: February 14, 2014. VerDate Mar<15>2010 18:44 Feb 12, 2014 Jkt 232001 Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SBIR Phase I contract review (Topic 329&330). Date: March 3, 2014. Time: 9:30 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W534, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, MD, Program & Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Drive, Room 7W412, Bethesda, MD 20892– 8328, 240–276–6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Clinical Studies. Date: March 5, 2014. Time: 2:30 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W602, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Delia Tang, MD Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W602, Bethesda, MD 20892–9750, 240–276–6456, tangd@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Bridging Cancer Mechanisms to Population Levels. Date: March 10, 2014. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ellen K Schwartz, EDD, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892–9750, 240–276–6384, schwarel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Biology 2. Date: March 24–25, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Hotel at Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W106, Rockville, MD 20892–2750, 240–276–6342, choe@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Omnibus Cancer Genetics. Date: March 27, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W412, Bethesda, MD 20892–9750, 240–276–6386, twinters@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 79, Number 30 (Thursday, February 13, 2014)]
[Notices]
[Page 8726]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03106]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Neural 
Oxidative Metabolism and Death Study Section, February 20, 2014, 08:00 
a.m. to February 21, 2014, 12:00 p.m., Fairmont Hotel San Francisco, 
950 Mason Street, San Francisco, CA, 94108 which was published in the 
Federal Register on January 23, 2014, 79 FR 3836-3838.
    The meeting will be held at The Argonaut Hotel, 495 Jefferson 
Street, San Francisco, CA 94109. The meeting date and time remain the 
same. The meeting is closed to the public.

    Dated: February 7, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03106 Filed 2-12-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.